Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.

PubWeight™: 2.70‹?› | Rank: Top 1%

🔗 View Article (PMID 8690638)

Published in Int J Radiat Oncol Biol Phys on July 01, 1996

Authors

C C Ling1, C Burman, C S Chui, G J Kutcher, S A Leibel, T LoSasso, R Mohan, T Bortfeld, L Reinstein, S Spirou, X H Wang, Q Wu, M Zelefsky, Z Fuks

Author Affiliations

1: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York NY 10021, USA.

Articles citing this

Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) (2012) 2.67

Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys (2011) 1.76

18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med (2009) 1.53

Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (1996) 1.14

Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol (2013) 1.06

Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2012) 1.00

Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol (2008) 0.99

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis. BMC Cancer (2003) 0.99

Therapeutic options for the management of pancreatic cancer. World J Gastroenterol (2014) 0.96

In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas (2012) 0.95

Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol (2013) 0.94

A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol (2010) 0.93

Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. World J Gastroenterol (2004) 0.93

Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Radiat Oncol (2008) 0.86

Intensity-modulated radiation therapy: emerging cancer treatment technology. Br J Cancer (2005) 0.84

Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys (2010) 0.81

Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol (2013) 0.80

Radiation proctopathy. Clin Colon Rectal Surg (2015) 0.79

The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer. Transl Lung Cancer Res (2015) 0.79

Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate. Indian J Urol (2012) 0.78

Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer. Radiat Oncol (2013) 0.78

Incorporating PET information in radiation therapy planning. Biomed Imaging Interv J (2007) 0.76

Mathematical Formulation of DMH-Based Inverse Optimization. Front Oncol (2014) 0.76

New approach in lung cancer radiotherapy offers better normal tissue sparing. Radiother Oncol (2016) 0.75

Intensity modulated radiation therapy. West J Med (1998) 0.75

Estimation of cell response in fractionation radiotherapy using different methods derived from linear quadratic model. Radiol Oncol (2015) 0.75

Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma. Front Oncol (2017) 0.75

Implementation of intensity modulated radiotherapy for prostate cancer in a private radiotherapy service in Mexico. Rep Pract Oncol Radiother (2014) 0.75

Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. Am J Mens Health (2015) 0.75

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States. Radiat Oncol J (2017) 0.75

Assessment and Comparison of Homogeneity and Conformity Indexes in Step-and-Shoot and Compensator-Based Intensity Modulated Radiation Therapy (IMRT) and Three-Dimensional Conformal Radiation Therapy (3D CRT) in Prostate Cancer. J Med Signals Sens (2017) 0.75

A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Int J Clin Oncol (2016) 0.75

Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors. Neurosurg Focus (2017) 0.75

Articles by these authors

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (1996) 6.75

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A (1999) 5.28

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys (1998) 3.82

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys (1989) 3.77

Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys (1991) 3.64

Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48

Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol (2003) 3.29

Advances in microbial amylases. Biotechnol Appl Biochem (2000) 3.11

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06

Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell (1995) 3.02

Structural basis of caspase-7 inhibition by XIAP. Cell (2001) 2.99

Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med (2000) 2.96

Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72

Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71

Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66

Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys Med Biol (2000) 2.65

Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U S A (2000) 2.54

Acquiring 4D thoracic CT scans using a multislice helical method. Phys Med Biol (2004) 2.42

Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell (2001) 2.39

Motion adaptive x-ray therapy: a feasibility study. Phys Med Biol (2001) 2.21

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med (1997) 2.21

Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell (1998) 2.18

Japanese yew poisoning of large domestic animals in the Midwest. J Am Vet Med Assoc (1977) 2.07

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res (1983) 2.04

Converting absorbed dose to medium to absorbed dose to water for Monte Carlo based photon beam dose calculations. Phys Med Biol (2000) 1.99

Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem (1999) 1.96

Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst (1990) 1.92

Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys (1991) 1.89

Ceramide enables fas to cap and kill. J Biol Chem (2001) 1.88

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81

Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys (1999) 1.81

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol (2000) 1.80

Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ (2010) 1.79

Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77

Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys (2000) 1.77

Quantifying the predictability of diaphragm motion during respiration with a noninvasive external marker. Med Phys (2003) 1.76

A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab (1999) 1.75

Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem (2001) 1.73

The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (1994) 1.73

Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. J Urol (1993) 1.72

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys (2000) 1.71

Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.71

Expression of basic fibroblast growth factor in normal human tissues. Lab Invest (1990) 1.70

Lung cancer after radiation therapy for breast cancer. Cancer (1993) 1.68

A gradient inverse planning algorithm with dose-volume constraints. Med Phys (1998) 1.66

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev (1990) 1.66

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science (1976) 1.66

IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65

Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res (2000) 1.65

Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones. Chem Biol (1999) 1.65

Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene (2011) 1.64

Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med (1998) 1.63

Dose-volume histograms. Int J Radiat Oncol Biol Phys (1991) 1.62

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol (1994) 1.62

Comparison of mechanized anterior capsulectomy and manual continuous capsulorhexis in pediatric eyes. J Cataract Refract Surg (1994) 1.61

Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer (1973) 1.60

Clinical electron-beam dosimetry: report of AAPM Radiation Therapy Committee Task Group No. 25. Med Phys (1991) 1.60

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis (2011) 1.59

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J (2001) 1.58

The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys (1991) 1.58

Algorithms and functionality of an intensity modulated radiotherapy optimization system. Med Phys (2000) 1.57

Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci (1991) 1.57

Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. J Clin Oncol (1998) 1.57

Reconsidering the definition of a dose-volume histogram. Phys Med Biol (2005) 1.56

The Gotfried percutaneous compression plate compared with the conventional classic hip screw for the fixation of intertrochanteric fractures of the hip. J Bone Joint Surg Br (2002) 1.54

Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys (1995) 1.54

Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys (1999) 1.53

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys (1989) 1.52

The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys (2000) 1.52

Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood (1994) 1.51

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys (1998) 1.51

When becometh less more? Int J Radiat Oncol Biol Phys (1995) 1.50

Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol (1997) 1.50

Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys (2000) 1.50

Normal basilar artery structure and biaxial mechanical behaviour. Comput Methods Biomech Biomed Engin (2008) 1.50

Detection of submicroscopic chromosomal aberrations by array-based comparative genomic hybridization in fetuses with congenital heart disease. Ultrasound Obstet Gynecol (2014) 1.48

The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.46

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys (1995) 1.46